LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-19
Case ID: NM_000546.5_c.63C_T_20261119_134204
Framework: ACMG/AMP 2015
Variant classification summary

NM_000546.5:c.63C>T

TP53  · NP_000537.3:p.(Asp21=)  · NM_000546.5
GRCh37: chr17:7579850 G>A  ·  GRCh38: chr17:7676532 G>A
Gene: TP53 Transcript: NM_000546.5
Final call
Benign
BA1 stand-alone benign BP4 supporting BP7 supporting
All criteria require review: For research and educational purposes only.
Gene
TP53
Transcript
NM_000546.5
Protein
NP_000537.3:p.(Asp21=)
gnomAD AF
0.0002397763574315801 (v4.1)
ClinVar
Benign
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
Benign: BA1 is met by the South Asian gnomAD v4.1 filtering allele frequency of 0.0037098.
2
Benign: BP4 supporting is met because maximum SpliceAI delta is 0.004, below 0.1.
3
Benign: BP7 supporting is met because the synonymous variant is outside the core splice motif with SpliceAI delta 0.004.
Final determination: Under the ClinGen TP53 Expert Panel Version 2.4 point-based framework, BA1 stand-alone benign plus BP4 and BP7 supporting scores -10 points, and a score of -7 or lower maps to Benign.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: c.63C>T is synonymous p.(Asp21=), with SpliceAI maximum delta 0.004 and no null or canonical splice consequence.
cspec pvs1_variant_assessment spliceai vcep_pvs1_flowchart vcep_pvs1_splicing_worksheet
PS1 N/A Not applicable: c.63C>T is synonymous p.Asp21=, so it creates no alternate amino-acid change eligible for the VCEP's PS1 comparison.
cspec PMID:20436704 PMID:32000721 PMID:18798306
PS2 Not assessed Not assessed: no documented proband cancer phenotype or confirmed maternity, paternity, and de novo status is available for assigning PS2 points.
cspec vcep_table_of_lfs_cancers_and_points_for_ps2_and_pp1_code_application
PS3 N/A Not applicable: the TP53 VCEP PS3 functional pathway covers missense variants and small in-frame deletions, whereas c.63C>T is synonymous and has no worksheet entry.
cspec vcep_flowchart_for_application_of_functional_rule_codes vcep_functional_worksheet PMID:32000721
PS4 Not assessed Not assessed: two breast-cancer cases versus one control gave OR 2.07 (95% CI 0.18-24.15), but no VCEP-defined LFS point-qualifying phenotype was reported.
cspec vcep_ps4_points_table PMID:32000721 PMID:20436704
PM1 N/A Not applicable: p.Asp21= is synonymous at codon 21, outside the VCEP's missense PM1 codons 175, 245, 248, 249, 273, and 282.
cspec hotspots
PM2 Not met Not met: gnomAD v4.1 total AF 0.000239776 exceeds the TP53 PM2 cutoff of 0.00003, with South Asian AF 0.00405103 also exceeding 0.00004.
cspec gnomad_v4 gnomad_v2
PM3 N/A Not applicable: the TP53 VCEP explicitly states that PM3 does not apply to TP53/Li-Fraumeni syndrome.
cspec
PM4 N/A Not applicable: the VCEP marks PM4 not applicable, and synonymous p.(Asp21=) causes no protein-length change.
cspec pvs1_variant_assessment
PM5 N/A Not applicable: c.63C>T is synonymous p.Asp21=, whereas every VCEP PM5 route requires a missense variant at the same amino-acid residue.
cspec pm5_candidates
PM6 N/A Not applicable: the TP53 VCEP drops PM6 and requires all de novo evidence to be evaluated through PS2.
cspec
PP1 Not assessed Not assessed: no affected relatives, obligate carriers, or countable cosegregating meioses are documented for applying PP1.
cspec vcep_table_of_lfs_cancers_and_points_for_ps2_and_pp1_code_application PMID:32000721 PMID:20436704 PMID:18798306
PP2 N/A Not applicable: the TP53 VCEP explicitly designates PP2 as not applicable.
cspec
PP3 Not met Not met: maximum SpliceAI delta 0.004 is below the TP53 VCEP PP3 threshold of 0.2 for exonic silent splice variants.
cspec vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7 spliceai vcep_pp3_bp4_codes vcep_tp53_single_amino_acid_deletions_bayesdel_scores_1
PP4 Not assessed Not assessed: the VCEP requires multigene-panel detection at VAF 5-35%, but no qualifying VAF or panel result is available.
cspec PMID:32000721
PP5 N/A Not applicable: the TP53 VCEP explicitly prohibits use of PP5.
cspec
BA1 Met Met: gnomAD v4.1 South Asian FAF 0.0037098 exceeds the TP53 VCEP BA1 threshold of 0.001 in a 91,088-allele subgroup.
cspec gnomad_v4
BS1 Not met Not met: South Asian gnomAD v4.1 FAF 0.0037098 is above the BS1 upper limit of 0.001 and instead meets BA1.
cspec gnomad_v4
BS2 Not assessed Not assessed: one healthy female control was reported, but age, unrelatedness, single-source status, and the required count of qualifying women are unavailable.
cspec gnomad_v4 PMID:32000721
BS3 N/A Not applicable: the TP53 VCEP BS3 functional pathway covers missense variants and small in-frame deletions, whereas c.63C>T is synonymous and has no worksheet entry.
cspec vcep_flowchart_for_application_of_functional_rule_codes vcep_functional_worksheet PMID:32000721
BS4 Not assessed Not assessed: no affected family members with variant-negative testing or other family-level non-segregation evidence is documented.
cspec PMID:32000721 PMID:20436704 PMID:18798306
BP1 N/A Not applicable: the TP53 VCEP excludes BP1 because truncating variants account for only a portion of disease-causing variants in these genes.
cspec
BP2 N/A Not applicable: the TP53 VCEP marks BP2 as not applicable, regardless of phase or co-occurrence with pathogenic variants.
cspec
BP3 N/A Not applicable: the VCEP marks BP3 not applicable, and synonymous p.(Asp21=) is not an in-frame deletion or insertion.
cspec pvs1_variant_assessment
BP4 Met Met at supporting: maximum SpliceAI delta 0.004 is below the TP53 VCEP BP4 silent-variant threshold of 0.1.
cspec vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7 spliceai vcep_pp3_bp4_codes vcep_tp53_single_amino_acid_deletions_bayesdel_scores_1
BP5 N/A Not applicable: the TP53 VCEP explicitly marks BP5 as not applicable.
cspec
BP6 N/A Not applicable: the TP53 VCEP explicitly prohibits use of BP6.
cspec
BP7 Met Met at supporting: synonymous c.63C>T is outside the core splice motif and has maximum SpliceAI delta 0.004, below the 0.1 threshold.
cspec vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7 spliceai vcep_pp3_bp4_codes vcep_tp53_single_amino_acid_deletions_bayesdel_scores_1
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.